| scholarly article | Q13442814 |
| P2093 | author name string | Ye Fang | |
| P2860 | cites work | Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation | Q24337851 |
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| A comprehensive pathway map of epidermal growth factor receptor signaling | Q24672490 | ||
| Label-free and real-time cell-based kinase assay for screening selective and potent receptor tyrosine kinase inhibitors using microelectronic sensor array | Q33251283 | ||
| Both ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling | Q33269156 | ||
| Duplexed label-free G protein--coupled receptor assays for high-throughput screening | Q33386660 | ||
| Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7 | Q33520184 | ||
| Analysis of molecular recognition using optical biosensors. | Q33745013 | ||
| Signaling networks: the origins of cellular multitasking | Q33923713 | ||
| Proteinase-activated receptors. | Q33947141 | ||
| Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors | Q33966121 | ||
| Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling | Q34041620 | ||
| Oligomerization of G-protein-coupled transmitter receptors. | Q34205602 | ||
| G-protein-coupled receptor phosphorylation: where, when and by whom | Q34735704 | ||
| Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors | Q35153734 | ||
| Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions | Q35599849 | ||
| Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 | ||
| New concepts in drug discovery: collateral efficacy and permissive antagonism | Q36303814 | ||
| Label-free cell-based assays with optical biosensors in drug discovery. | Q36658135 | ||
| Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains | Q36872222 | ||
| GPCR functional selectivity has therapeutic impact | Q36880909 | ||
| The evasive nature of drug efficacy: implications for drug discovery | Q36894549 | ||
| Impedance-based cellular assay technologies: recent advances, future promise | Q36953940 | ||
| GPR40: good cop, bad cop? | Q37163504 | ||
| Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function | Q37170755 | ||
| Label-free cell-based assays for GPCR screening. | Q37184789 | ||
| Cellular assays as portals to seven-transmembrane receptor-based drug discovery | Q37553926 | ||
| 7TM pharmacology measured by label-free: a holistic approach to cell signalling | Q37578079 | ||
| Label-free optical biosensor for probing integrative role of adenylyl cyclase in G protein-coupled receptor signaling | Q39825140 | ||
| The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons | Q39884306 | ||
| Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity | Q39884754 | ||
| The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation | Q39916587 | ||
| Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity | Q39931162 | ||
| Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells. | Q40017822 | ||
| A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties | Q40157034 | ||
| Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. | Q40185924 | ||
| Resonant waveguide grating biosensor for living cell sensing. | Q40269125 | ||
| Characteristics of dynamic mass redistribution of epidermal growth factor receptor signaling in living cells measured with label-free optical biosensors | Q40379956 | ||
| Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells | Q40391976 | ||
| Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. | Q40685957 | ||
| G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. | Q41304898 | ||
| Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization | Q41852598 | ||
| Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states | Q42046378 | ||
| Non-invasive Optical Biosensor for Probing Cell Signaling. | Q42122607 | ||
| Infrared surface plasmon resonance: a novel tool for real time sensing of variations in living cells | Q43167195 | ||
| Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors | Q44809000 | ||
| Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists | Q46427567 | ||
| Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. | Q46477127 | ||
| Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells | Q46785891 | ||
| Label-free assays on the BIND system. | Q51823256 | ||
| Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. | Q52540974 | ||
| The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists. | Q52926779 | ||
| Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor | Q71514922 | ||
| Kinetics of adhesion and spreading of animal cells | Q81613496 | ||
| P433 | issue | 1 | |
| P304 | page(s) | e5-e11 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Drug discovery today. Technologies | Q27723323 |
| P1476 | title | Label-Free Receptor Assays | |
| P478 | volume | 7 |
| Q30420969 | A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling. |
| Q37694673 | A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity |
| Q39103103 | A label-free optical biosensor with microfluidics identifies an intracellular signalling wave mediated through the β(2)-adrenergic receptor |
| Q28740731 | Agonist-directed desensitization of the β2-adrenergic receptor |
| Q36841982 | Allosteric modulation and functional selectivity of G protein-coupled receptors. |
| Q38452129 | Compound annotation with real time cellular activity profiles to improve drug discovery |
| Q38775057 | Discovery of 2-(4-methylfuran-2(5H)-ylidene)malononitrile and thieno[3,2-b]thiophene-2-carboxylic acid derivatives as G protein-coupled receptor 35 (GPR35) agonists |
| Q31148493 | Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors |
| Q34376698 | Dynamic mass redistribution assay decodes differentiation of a neural progenitor stem cell |
| Q35751575 | Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors. |
| Q30420962 | Evaluating Inhibition of the Epidermal Growth Factor (EGF)-Induced Response of Mutant MCF10A Cells with an Acoustic Sensor |
| Q38191007 | G-protein-coupled receptor regulation of de novo purine biosynthesis: a novel druggable mechanism. |
| Q34054724 | GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis. |
| Q42722466 | GPR35 is a target of the loop diuretic drugs bumetanide and furosemide |
| Q58687097 | Label-Free Biosensors for Cell Biology |
| Q37381371 | Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors |
| Q39013350 | Label-free cell-based dynamic mass redistribution assays |
| Q37681372 | Label-free drug discovery |
| Q39119572 | Label-free integrative pharmacology on-target of drugs at the β(2)-adrenergic receptor |
| Q28709650 | Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family |
| Q28730612 | Label-free phenotypic profiling identified D-luciferin as a GPR35 agonist |
| Q28477403 | Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target |
| Q38031893 | Ligand-receptor interaction platforms and their applications for drug discovery. |
| Q38044984 | New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2. |
| Q34343837 | PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS |
| Q38327332 | Progress of new label-free techniques for biosensors: a review. |
| Q34438026 | Resonant waveguide grating imager for live cell sensing. |
| Q47685791 | The development of label-free cellular assays for drug discovery |
| Q37424854 | The purinosome, a multi-protein complex involved in the de novo biosynthesis of purines in humans |
| Q26823570 | Total internal reflection fluorescence quantification of receptor pharmacology |
| Q46013288 | Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery. |
Search more.